Tata Mid Cap Fund
The fund is heavily tilted toward financials and pharmaceuticals, betting on India's credit growth and domestic consumption recovery. The manager significantly increased conviction in infrastructure plays, notably BHEL, while building defensive cash positions through repo holdings—signaling caution despite maintaining nearly 94% equity exposure. The concentrated top-10 structure and selective exits suggest a quality-focused approach navigating near-term volatility in midcaps.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Primary | ₹445.6774 | +1.32% | +8.25% | +19.99% | +17.63% |
Portfolio Metrics(latest month)
vs Category Peers
Active Stock PickerActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| (A) TREPS | 2.01% |
| B) REPO | 2.44% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | MANKIND PHARMA LTD INE634S01028 | 3.21% |
| 2 | FEDERAL BANK LTD INE171A01029 | 3.07% |
| 3 | BHARAT HEAVY ELECTRICALS LTD INE257A01026 | 2.90% |
| 4 | INDIAN BANK INE562A01011 | 2.79% |
| 5 | INDUSIND BANK LTD INE095A01012 | 2.78% |
| 6 | AU SMALL FINANCE BANK LTD INE949L01017 | 2.72% |
| 7 | MAX FINANCIAL SERVICES LTD INE180A01020 | 2.69% |
| 8 | UPL LTD INE628A01036 | 2.63% |
| 9 | GLENMARK PHARMACEUTICALS LTD INE935A01035 | 2.58% |
| 10 | B) REPO | 2.44% |
| 11 | MARICO LTD INE196A01026 | 2.42% |
| 12 | INDUS TOWERS LTD INE121J01017 | 2.27% |
| 13 | ONE 97 COMMUNICATIONS LTD INE982J01020 | 2.15% |
| 14 | MPHASIS LTD INE356A01018 | 2.04% |
| 15 | (A) TREPS | 2.01% |
| 16 | L&T FINANCE LTD INE498L01015 | 2.00% |
| 17 | UNO MINDA LTD INE405E01023 | 1.99% |
| 18 | BSE LTD INE118H01025 | 1.95% |
| 19 | CASH / NET CURRENT ASSET | 1.92% |
| 20 | BHARTI HEXACOM LTD INE343G01021 | 1.90% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does Tata Mid Cap Fund hold?
Tata Mid Cap Fund holds 62 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 14.75% of NAV.
What is the largest holding in Tata Mid Cap Fund?
The largest position in Tata Mid Cap Fund is MANKIND PHARMA LTD, accounting for 3.21% of NAV in the Pharmaceuticals & Biotechnology sector.
Is Tata Mid Cap Fund a concentrated or diversified fund?
With a Gini coefficient of 0.260, Tata Mid Cap Fund is well-diversified. The HHI concentration index is 17,212 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 14.75% of the portfolio.
What is the market cap allocation of Tata Mid Cap Fund?
Based on SEBI's AMFI classification, Tata Mid Cap Fund's equity portfolio is split as: Large Cap: 8.90%, Mid Cap: 75.41%, Small Cap: 9.32%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does Tata Mid Cap Fund invest in most?
Tata Mid Cap Fund has the highest allocation to Banks (12.23%), Pharmaceuticals & Biotechnology (9.01%), Auto Components (7.24%). The fund is invested across 31 sectors in total.
How actively managed is Tata Mid Cap Fund compared to other Mid Cap Fund funds?
Tata Mid Cap Fund has an Active Share of 60.46%, classifying it as "Active Stock Picker" among 30 Mid Cap Fund peers. This indicates a moderate level of differentiation from category peers.
What changed in Tata Mid Cap Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, Tata Mid Cap Fund added 2 new stocks (including (A) TREPS) and exited 3 stocks (including KAJARIA CERAMICS LTD). Total holding count decreased from 66 to 65 stocks.